Earnings History Data for Celularity Inc. (CELU) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Celularity Inc.
Celularity Inc. is a clinical stage biotechnology company. It involved in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells engineered with a CAR and mesenchymal-like adherent stromal cells targeting indications across cancer, infectious and degenerative diseases. Celularity Inc., formerly known as GX Acquisition Corp., is based in NEW YORK.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10-11-2022 | AH | CELU | Celularity Inc. | 264.91 | 0.03 | -0.26 | 0.40 | Celularity GAAP EPS of $0.03 [11/10/2022 5:53 PM] |
2.04 | -0.09 (-4.23%) |
2.20 | 0.07 (3.21%) |
1.67 - 13.19 | 906,712 | 280,000 | 642 | ||
| 09-08-2022 | AH | 4:10 PM ET (Aug 9) |
CELU | Celularity | 418.00 | 0.03 | -0.26 | 0.00 | Celularity GAAP EPS of $0.32 beats by $0.58, revenue of $3.78M misses by $1.47M [8/9/2022 5:24 PM] |
3.23 | 0.10 (3.19%) |
3.14 | 0.01 (0.32%) |
2.72 - 13.19 | 687,324 | 490,000 | 378 | |
| 16-05-2022 | AH | 4:05 PM ET (May 16) |
CELU | Celularity | 795.00 | -0.48 | -0.23 | 0.00 | Celularity GAAP EPS of -$0.48, revenue of $5.9M [5/16/2022 4:58 PM] |
7.54 | 1.12 (17.45%) |
6.30 | -0.12 (-1.87%) |
3.63 - 13.40 | 446,119 | 540,000 | 173 | |
| 31-03-2022 | AH | CELU | Celularity | 1,005 | -0.03 | -0.29 | 0.00 | Celularity GAAP EPS of -$0.03, revenue of $4.86M [3/31/2022 4:57 PM] |
8.90 | 0.19 (2.18%) |
8.71 | 0.0 (0.00%) |
3.63 - 13.40 | 178,230 | 160,000 | 114 | ||
| 12-11-2021 | AH | CELU | Celularity | 893.00 | 0.40 | -0.29 | 0.00 | Celularity reports Q3 results [11/12/2021 4:11 PM] |
6.91 | -0.19 (-2.74%) |
0.0 | 0.0 (0.00%) |
6.00 - 13.40 | 87,166 | 50,000 | 0 | ||